|
Volumn 408, Issue 6811, 2000, Pages 483-488
|
Remission in models of type 1 diabetes by gene therapy using a single-chain insulin analogue
a a b a a,c |
Author keywords
[No Author keywords available]
|
Indexed keywords
C PEPTIDE;
COMPLEMENTARY DNA;
GLUCOSE;
INSULIN DERIVATIVE;
MESSENGER RNA;
PLASMID DNA;
VIRUS VECTOR;
ADENO ASSOCIATED VIRUS;
ANIMAL MODEL;
ARTICLE;
AUTOIMMUNE DISEASE;
CONTROLLED STUDY;
DIABETES MELLITUS;
GENE THERAPY;
GLUCOSE BLOOD LEVEL;
INSULIN DEPENDENT DIABETES MELLITUS;
INSULIN TREATMENT;
MOUSE;
NONHUMAN;
PANCREAS ISLET BETA CELL;
PRIORITY JOURNAL;
RAT;
STREPTOZOCIN DIABETES;
VIRUS RECOMBINANT;
ANIMALS;
BASE SEQUENCE;
BLOOD GLUCOSE;
CLONING, MOLECULAR;
DEPENDOVIRUS;
DIABETES MELLITUS, EXPERIMENTAL;
DIABETES MELLITUS, TYPE 1;
DNA, COMPLEMENTARY;
DNA, RECOMBINANT;
ESCHERICHIA COLI;
GENE EXPRESSION;
GENE THERAPY;
GENETIC VECTORS;
GLUCOSE TOLERANCE TEST;
HALF-LIFE;
HEPATOCYTES;
INSULIN;
LIVER;
MALE;
MICE;
MICE, INBRED NOD;
MOLECULAR SEQUENCE DATA;
PLASMIDS;
PROMOTER REGIONS (GENETICS);
RATS;
RATS, SPRAGUE-DAWLEY;
ADENO-ASSOCIATED VIRUS;
ANIMALIA;
SIA;
|
EID: 0034707028
PISSN: 00280836
EISSN: None
Source Type: Journal
DOI: 10.1038/35044106 Document Type: Article |
Times cited : (219)
|
References (28)
|